Enovis Corporation
ENOV
Jodie situation report
Enovis Corporation's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 6 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- ENOV's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ENOV's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ENOV
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ESABESAB CorporationpartnerFeb 26, 2026 ▾
“The Company sold its air & gas handling business in 2019 and completed the separation of its fabrication technology business into a into an independent, publicly traded company (ESAB) in 2022 (the “Separation”).”
SYKStryker CorporationcompetitorFeb 26, 2026 ▾
“Key competitors for our Reconstructive segment include Stryker, Zimmer Biomet, and DePuy Synthes, the medical device business within Johnson & Johnson.”
Depended on by
OFIXOrthofix Medical Inc.competitorFeb 24, 2026 ▾
“Our Bone Growth Therapies product category competes principally with similar products marketed by EBI, Enovis, Bioventus, Theragen, and Xstim.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ENOV is currently a Participant in the organic co-movement group Medical Devices & Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ENOV; it is not active in the latest market snapshot.